WO1994014964A1 - Modified cutinases, dna, vector and host - Google Patents
Modified cutinases, dna, vector and host Download PDFInfo
- Publication number
- WO1994014964A1 WO1994014964A1 PCT/EP1993/003551 EP9303551W WO9414964A1 WO 1994014964 A1 WO1994014964 A1 WO 1994014964A1 EP 9303551 W EP9303551 W EP 9303551W WO 9414964 A1 WO9414964 A1 WO 9414964A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cutinase
- gene
- sequence
- enzyme
- cutinase variant
- Prior art date
Links
- 108010005400 cutinase Proteins 0.000 title claims abstract description 301
- 239000013598 vector Substances 0.000 title claims description 23
- 102000004190 Enzymes Human genes 0.000 claims abstract description 65
- 108090000790 Enzymes Proteins 0.000 claims abstract description 65
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 36
- 241000427940 Fusarium solani Species 0.000 claims description 84
- 239000012634 fragment Substances 0.000 claims description 78
- 108090000623 proteins and genes Proteins 0.000 claims description 77
- 238000000034 method Methods 0.000 claims description 42
- 108020004414 DNA Proteins 0.000 claims description 36
- 244000005700 microbiome Species 0.000 claims description 35
- 239000003599 detergent Substances 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 33
- 150000001413 amino acids Chemical group 0.000 claims description 30
- 239000002773 nucleotide Substances 0.000 claims description 29
- 125000003729 nucleotide group Chemical group 0.000 claims description 29
- 108020004705 Codon Proteins 0.000 claims description 24
- 230000014509 gene expression Effects 0.000 claims description 24
- 125000000539 amino acid group Chemical group 0.000 claims description 23
- 230000035772 mutation Effects 0.000 claims description 23
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 17
- 108091033319 polynucleotide Proteins 0.000 claims description 16
- 102000040430 polynucleotide Human genes 0.000 claims description 16
- 239000002157 polynucleotide Substances 0.000 claims description 16
- 238000000855 fermentation Methods 0.000 claims description 15
- 230000004151 fermentation Effects 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- 230000002209 hydrophobic effect Effects 0.000 claims description 14
- 108091026890 Coding region Proteins 0.000 claims description 10
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 239000003550 marker Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 8
- 230000009881 electrostatic interaction Effects 0.000 claims description 8
- 230000002255 enzymatic effect Effects 0.000 claims description 8
- 230000004927 fusion Effects 0.000 claims description 8
- 108020004999 messenger RNA Proteins 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 8
- 108020004511 Recombinant DNA Proteins 0.000 claims description 7
- 241000233866 Fungi Species 0.000 claims description 6
- 230000002950 deficient Effects 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 230000010076 replication Effects 0.000 claims description 6
- 241000222201 Colletotrichum capsici Species 0.000 claims description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- 241000228212 Aspergillus Species 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- 241000206602 Eukaryota Species 0.000 claims description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002243 precursor Substances 0.000 claims description 3
- 102220013562 rs132630314 Human genes 0.000 claims description 3
- 235000004400 serine Nutrition 0.000 claims description 3
- 235000008521 threonine Nutrition 0.000 claims description 3
- 241001529387 Colletotrichum gloeosporioides Species 0.000 claims description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- 241000235648 Pichia Species 0.000 claims description 2
- 108091036078 conserved sequence Proteins 0.000 claims description 2
- 230000010354 integration Effects 0.000 claims description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 2
- 230000035800 maturation Effects 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 102220169347 rs201929423 Human genes 0.000 claims description 2
- 102220185905 rs61754326 Human genes 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 241001344133 Magnaporthe Species 0.000 claims 1
- 241000235070 Saccharomyces Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 54
- 239000013612 plasmid Substances 0.000 description 32
- 108090001060 Lipase Proteins 0.000 description 27
- 102000004882 Lipase Human genes 0.000 description 26
- 239000004367 Lipase Substances 0.000 description 26
- 235000019421 lipase Nutrition 0.000 description 26
- 241000588724 Escherichia coli Species 0.000 description 25
- 102220505831 Borealin_R17E_mutation Human genes 0.000 description 24
- 230000000694 effects Effects 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 108091034117 Oligonucleotide Proteins 0.000 description 17
- 239000002299 complementary DNA Substances 0.000 description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 16
- 230000002366 lipolytic effect Effects 0.000 description 16
- 238000010276 construction Methods 0.000 description 15
- 108010076504 Protein Sorting Signals Proteins 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 13
- 238000013459 approach Methods 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- 241001513093 Aspergillus awamori Species 0.000 description 11
- 239000013613 expression plasmid Substances 0.000 description 11
- 239000004744 fabric Substances 0.000 description 11
- 108700005078 Synthetic Genes Proteins 0.000 description 10
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 102220556536 Sodium/calcium exchanger 1_L51A_mutation Human genes 0.000 description 9
- 239000013604 expression vector Substances 0.000 description 9
- 239000001573 invertase Substances 0.000 description 9
- 235000011073 invertase Nutrition 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 230000002538 fungal effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 7
- 108700026244 Open Reading Frames Proteins 0.000 description 7
- 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 101150009573 phoA gene Proteins 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 238000010561 standard procedure Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000222199 Colletotrichum Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- 101150025953 gal7 gene Proteins 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- 239000004006 olive oil Substances 0.000 description 6
- 235000008390 olive oil Nutrition 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 5
- 102100039555 Galectin-7 Human genes 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 125000000129 anionic group Chemical group 0.000 description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 101150054232 pyrG gene Proteins 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000329 molecular dynamics simulation Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 239000013615 primer Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 239000010457 zeolite Substances 0.000 description 4
- 241000351920 Aspergillus nidulans Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229920000832 Cutin Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000223198 Humicola Species 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241001344131 Magnaporthe grisea Species 0.000 description 2
- 108010021466 Mutant Proteins Proteins 0.000 description 2
- 102000008300 Mutant Proteins Human genes 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 150000004996 alkyl benzenes Chemical class 0.000 description 2
- 108010030291 alpha-Galactosidase Proteins 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- -1 however Proteins 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000037432 silent mutation Effects 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229960001922 sodium perborate Drugs 0.000 description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
- 229910052911 sodium silicate Inorganic materials 0.000 description 2
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 1
- 241001157812 Alternaria brassicicola Species 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108010031746 Dam methyltransferase Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 1
- 102100031375 Endothelial lipase Human genes 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- 102220492781 Nuclear RNA export factor 1_R17K_mutation Human genes 0.000 description 1
- 241001643667 Orpha Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- 241000813090 Rhizoctonia solani Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 102220522758 Serine/arginine-rich splicing factor 3_R88E_mutation Human genes 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 102220509220 Sphingosine 1-phosphate receptor 1_T80H_mutation Human genes 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- KRDSCBLRHORMRK-JXUBOQSCSA-N Thr-Lys-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O KRDSCBLRHORMRK-JXUBOQSCSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000020054 awamori Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 102220396199 c.152T>C Human genes 0.000 description 1
- 102220367265 c.161G>T Human genes 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 101150109823 ds gene Proteins 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 102200086299 rs104894153 Human genes 0.000 description 1
- 102200074436 rs104894784 Human genes 0.000 description 1
- 102220329755 rs373637566 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 108010062040 wax-ester hydrolase Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Definitions
- the present invention generally relates to the field of lipolytic enzymes. More in particular, the invention is concerned with lipolytic enzymes which have been modified by means of reco binant DNA techniques, with methods for their production and with their use, particularly in enzymatic detergent compositions.
- Lipolytic enzymes are enzymes which are capable of hydrolysing triglycerides into free fatty acids and diglycerides, monoglycerides and eventually glycerol. They can also split more complex esters such as cutin layers in plants or sebum of the skin. Lipolytic enzymes are used in industry for various enzymatic processes such as the inter- and trans-esterification of triglycerides and the synthesis of esters. They are also used in detergent compositions with the aim to improve the fat-removing properties of the detergent product.
- lipases (EC 3.1.1.3).
- EP-A-258 068 and EP-A-305 216 both Novo Nordisk) both describe production of fungal lipases via heterologous host micro-organisms by means of rDNA techniques, especially the lipase from Thermomyces lanu inosus/Humicola lanu ⁇ inosa.
- EP-A-331 376 (Amano) describes lipases and their production by rDNA techniques, and their use, including an amino acid sequence of lipase from Pseudomonas cepacia.
- lipases produced by rDNA technique are given in WO 89/09263 and EP-A- 218 272 (both Gist-Brocades) .
- Lipolase TM
- a characteristic feature of lipases is that they exhibit interfacial activation. This means that the enzyme activity is much higher on a substrate which has formed interfaces or micelles, than on fully dissolved substrate. Interface activation is reflected in a sudden increase in lipolytic activity when the substrate concentration is raised above the critical micel concentration (CMC) of the substrate, and interfaces are formed. Experimentally this phenomenon can be observed as a discontinuity in the graph of enzyme activity versus substrate concentration.
- CMC critical micel concentration
- a helical lid covers the catalytic binding site. Upon binding to the lipid substrate, the lid is displaced and the catalytic site is exposed. The helical lid is also believed to interact with the lipid interface, thus allowing the enzyme to remain bound to the interface.
- WO-A-92/05249 discloses genetically modified lipases, in particular the lipase from Humicola lanuqinosa. which have been modified at the lipid contact zone.
- the lipid contact zone is defined in the application as the surface which in the active form is covered by the helical lid.
- the modifications involve deletion or substitution of one or more amino acid residues in the lipid contact zone, so as to increase the electrostatic charge and/or decrease the hydrophobicity of the lipid contact zone, or so as to change the surface conformation of the lipid contact zone.
- Cutinases are a sub-class of enzymes (EC 3.1.1.50), the wax ester hydrolases. These enzymes are capable of degrading cutin, a network of esterified long-chain fatty acids and fatty alcohols which occurs in plants as a protective coating on leaves and stems. In addition, they possess some lipolytic activity, i.e. they are capable of hydrolysing triglycerides. Thus they can be regarded as a special kind of lipases. Contrary to lipases, however, cutinases do not exhibit any substantial interfacial activation.
- Cutinases can be obtained from a number of sources, such as plants (e.g. pollen) , bacteria and fungi. Because of their fat degrading properties, cutinases have been proposed as ingredients for enzymatic detergent compositions. For example, WO-A-88/09367 (Genencor) suggests combinations of a surfactant and a substantially pure bacterial cutinase enzyme to formulate effective cleaning compositions. Disclosed are detergent compositions comprising a cutinase obtained from the Gram negative bacterium Pseudomonas putida ATCC 53552.
- the cutinase gene from Fusarium solani pisi has been cloned and sequenced (Ettinger et al., (1987) Biochemistry 26, 7883-7892).
- WO-A-90/09446 Plant Genetics Systems describes the cloning and production of this gene in E. coli.
- the cutinase can efficiently catalyse the hydrolysis and the synthesis of esters in aqueous and non-aqueous media, both in the absence and the presence of and interface between the cutinase and the substrate.
- this cutinase could be used to produce cleaning agents such as laundry detergents and other specialized fat dissolving preparations such as cosmetic compositions and shampoos.
- Cutinases as lipolytic enzymes which exhibit substantially no interfacial activation. Cutinases therefore differ from classical lipases in that they do not possess a helical lid covering the catalytic binding site.
- Cutinases in particular the cutinase from Fusarium solani pisi. exhibit a clear in-the- wash effect.
- Cutinase variants having improved in-the-wash lipolytic activity in anionic-rich detergent compositions, and for methods for producing such enzymes.
- Cutinase variants wherein the amino acid sequence has been modified in such way that the compatibility to anionic surfactants has been improved. More in particular, it was found that the lipolytic activity of eukaryotic Cutinases, more in particular of Cutinases from Fusarium solani pisi, Colletotrichu capsici. Colletotrichum qloeosporiodes and Maqnaporthe crrisea. in anionic-rich detergent compositions may be improved by reducing the binding of anionic surfactants to the enzyme.
- a Cutinase variant of a parent Cutinase wherein the amino acid sequence has been modified in such way that the compatibility to anionic surfactants has been improved, in particular by reducing the binding of anionic surfactants to the enzyme.
- Cutinases can be obtained from a number of sources, such as plants (e.g. pollen) , bacteria and fungi.
- Eukaryotic Cutinases can be obtained from various sources, such as plants (e.g. pollen) , or fungi.
- the group of (eukaryotic) fungal Cutinases appears to comprise two families with different specificities, leaf- specificity and stem-specificity.
- Cutinases with leaf-specificity tend to have an acidic or neutral pH-optimum, whereas Cutinases with stem-specificity tend to have an alkaline pH-optimum. Cutinases having an alkaline pH-optimum are more suitable for use in alkaline built detergent compositions such as heavy duty fabric washing powders and liquids. Cutinase having an acidic to neutral pH-optimum are more suitable for light duty products or rinse conditioners, but also for industrial cleaning products. in the following Table I, four different Cutinases with stem-specificity are listed, together with their pH- optima. TABLE I
- Cutinases which can be derived from wild type Fusarium solani pisi (Ettinger et al. 1987) . When used in certain detergent compositions, this Cutinase exhibits clear "in-the-wash” effects.
- Cutinases having a high degree of ho ology of their amino acid sequence to the Cutinase from Fusarium solani pisi.
- Examples are the Cutinases from Colletotrichum capsici. Colletotrichum loeosporiodes and Maqnaporthe risea.
- Figure 11 the partial amino acid sequences of these Cutinases are shown and it can be seen that there is a high degree of homology.
- the 3D-structure of the cutinase from Colletotrichum qloeosporiodes was obtained by applying rule-based comparative modelling techniques as implemented in the COMPOSER module of the SYBYL molecular modelling software package (TRIPOS associates, Inc. St. Louis, Missouri) .
- the obtained model of the Colletotrichum qloeosporiodes cutinase was refined by applying energy minimization (EM) and molecular dynamics (MD) techniques as implemented in the BIOSYM molecular modelling software package (BIOSYM, San Diego, California) .
- EM energy minimization
- MD molecular dynamics
- Model quality was assessed by criteria such as number and quality of hydrogen bonds, hydrogen bonding patterns in the secondary structure elements, the orientation of peptide units, the values of and main chain dihedral angles, the angle of interaction of aromatic groups and the sizes of cavities. Moreover, the model was checked for inappropriately buried charges, extremely exposed hydrophobic residues and energetically unfavourable positions of disulphide bridges. Relevant side- chain rotamers were selected from the Ponder & Richards rota er library (Ponder et al. (1987) J.Mol.Biol. 193, 775- 791) .
- the present invention shows that Cutinases can be modified in such a way that the interaction with anionic surfactants can be reduced without changing the "in-the-wash" performance of the modified Cutinase.
- the binding of anionic surfactants to the enzyme may be reduced by reducing the electrostatic interaction between the anionic surfactant and the enzyme. For instance, by replacing one or more positively charged arginine residues which are located close to a hydrophobic patch capable of binding the apolair tail of an anionic surfactant, by lysine residues. It is also possible to reduce the electrostatic interaction between the anionic surfactant and the enzyme shielding the positive charge of such an arginine residue by introducing within a distance of about 6 A from said arginine a negative charge, e.g. an glutamic acid residue.
- the electrostatic interaction between the anionic surfactant and the enzyme may be reduced by replacing one or more positively charged arginine residues which are located close to a hydrophobic patch capable of binding the apolair tail of the anionic surfactant, by uncharged amino acid residues.
- the electrostatic interaction between the anionic surfactant and the enzyme may reduced by replacing one or more positively charged arginine residues which are located close to a hydrophobic patch capable of binding the apolair tail of the anionic surfactant, by negatively charged amino acid residues.
- the Cutinases variants produced according to the invention can bring advantage in enzyme activity, when used as part of an anionic-rich detergent or cleaning compositions.
- anionic-rich means that the detergent or cleaning composition contains a surfactant system which consists for more than 5%, generally more than 10%, and in particular more than 20% of anionic surfactants.
- the Cutinase variants of the present invention were found to possess an improved in-the-wash performance during the main cycle of a wash process.
- in-the-wash performance during the main cycle of a wash process it is meant that a detergent composition containing the enzyme is capable of removing a significant amount of oily soil from a soiled fabric in a single wash process in a European type of automatic washing machine, using normal washing conditions as far as concentration, water hardness, temperature, are concerned.
- the conventional commercially available lipolytic enzyme Lipolase (TM) ex Novo Nordisk does not appear to have any significant in-the-wash effect at all on oily soil.
- the in-the-wash effect of an enzyme on oily soil can be assessed using the following assay.
- the common method is to extract the testcloth with petroleum ether in a Soxhlet extraction apparatus, distilling off the solvent and determining the percentage residual fatty material as a fraction of the initial amount of fat on the cloth by weighing.
- brominated olive oil is used to soil the test cloths (Richards, S., Morris, M.A. and Arklay, T.H. (1968), Textile Research Journal 3_8, 105-107) .
- Each test cloth is then incubated in 30 ml wash liquor in a 100 ml polystyrene bottle.
- a series of bottles is then agitated in a washing machine filled with water and using a normal 30°C main wash programme. After the main wash, the test cloths are carefully rinsed in cold water during 5 seconds. Immediately after the rinse, the test cloths dried in a dryer with cold air. After drying the amount of residual fat can be determined by measuring the bromine content of the cloth by means of X-ray. fluorescence spectrometry.
- the fat removal can be determined as a percentage of the amount which was initially present on the test cloth, as follows:
- Bromine bw wherein: Bromine bw denotes the percentage bromine on the cloth before the wash and Bromine aw the percentage bromine after the wash.
- a further method of assessing the enzymatic activity is by measuring the reflectance at 460 nm according to standard techniques.
- a modified, mutated or mutant enzyme or a variant of an enzyme means an enzyme that has been produced by a mutant organism which is expressing a mutant gene.
- a mutant gene (other than one containing only silent mutations) means a gene encoding an enzyme having an amino acid sequence which has been derived directly or indirectly, and which in one or more locations is different, from the sequence of a corresponding parent enzyme.
- the parent enzyme means the gene product of the corresponding unaltered gene.
- a silent mutation in a gene means a change or difference produced in the polynucleotide sequence of the gene which (owing to the redundancy in the codon-amino acid relationships) leads to no change in the amino acid sequence of the enzyme encoded by that gene.
- a mutant or mutated micro-organism means a micro ⁇ organism that is, or is descended from, a parent micro- organism subjected to mutation in respect of its gene for the enzyme. Such mutation of the organism may be carried out either (a) by mutation of a corresponding gene (parent gene) already present in the parent micro-organism, or (b) by the transfer (introduction) of a corresponding gene obtained directly or indirectly from another source, and then introduced (including the mutation of the gene) into the micro-organism which is to become the mutant micro-organism.
- a host micro-organism is a micro-organism of which a mutant gene, or a transferred gene of other origin, forms part. In general it may be of the same or different strain or species origin or descent as the parent micro-organism.
- a mutation present in the amino acid sequence of a protein may be described by the position and nature of the mutation in the following abbreviated way: by the identity of an original amino acid residue affected by the mutation; the site (by sequence number) of the mutation; and by the identity of the amino acid residue substituted there in place of the original. If there is an insertion of an extra amino acid into the sequence, its position is indicated by one or more subscript letters attached to the number of the last preceding member of the regular sequence or reference sequence.
- Argl7Glu a mutant characterised by substitution of Arginine by Glutamine in position 17 is designated as: Argl7Glu or R17E.
- a (hypothetical) insertion of an additional amino acid residue such as proline after the Arginine would be indicated as Argl7ArgPro or R17RP, alternatively as *17aP, with the inserted residue designated as position number 17a.
- a (hypothetical) deletion of Arginine in the same position would be indicated by Argl7* or R17*.
- the asterisk stands either for a deletion or for a missing amino acid residue in the position designated, whether it is reckoned as missing by actual deletion or merely by comparison or homology with another or a reference sequence having a residue in that position.
- R17E+S54I+A128F designates a mutant protein carrying three mutations by substitution, as indicated for each of the three mentioned positions in the amino acid sequence.
- the mutations given in the following Table may be combined if desired.
- a process for producing the Cutinase variants of the invention is provided.
- Naturally occurring Cutinase producing micro-organisms are usually plant pathogens and these micro-organisms are not very suitable to act as host cell for modified Cutinases genes. Consequently, the genes coding for modified (pro) Cutinases were integrated in rDNA vectors that can be transferred into the preferred host micro-organism for rDNA technology.
- rDNA vectors essentially similar to the rDNA vector described in WO-A-90/09446 can be used.
- Naturally occurring Cutinase producing micro ⁇ organisms are not very suitable for fermentation processes.
- rDNA modified (host micro-organisms) are bacteria, among others, Bacilli, Corvnebacteria, Staphylococci and Streptomyces, or lower eukaryotes such as Saccharomyces cerevisiae and related species, Kluvveromyces marxianus and related species,
- Preferred host micro-organisms are the lower eukaryotes, because these microorganisms are producing and secreting enzymes very well in fermentation processes and are able to glycolysate the Cutinase molecule. Glycosylation can contribute to the stability of the Cutinase in detergent systems.
- the invention also provides genetic material derived from the introduction of modified eukaryotic Cutinase genes, e.g. the gene from Fusarium solani pisi. into cloning rDNA vectors, and the use of these to transform new host cells and to express the genes of the Cutinase variants in the new host cells.
- modified eukaryotic Cutinase genes e.g. the gene from Fusarium solani pisi. into cloning rDNA vectors
- the Cutinase-encoding nucleotide sequence derived from the organism of origin can be modified in such a way that at least one codon, and preferably as many codons as possible, are made the subject of 'silent' mutations to form codons encoding equivalent aminoacid residues and being codons preferred by a new host, thereby to provide in use within the cells of such host a messenger-RNA for the introduced gene of improved stability.
- the nucleotide sequence can be derived for example fro :
- a naturally occurring nucleotide sequence e.g. encoding the original amino acid sequence of the prepro- or pro- cutinase produced by Fusarium solani pisi
- a naturally occurring nucleotide sequence e.g. encoding the original amino acid sequence of the prepro- or pro- cutinase produced by Fusarium solani pisi
- nucleotide sequences derived from one of the nucleotide sequences mentioned in preceding paragraphs a or b coding for a Fusarium solani pisi Cutinase with a different amino acid sequence but having superior stability and/or activity in detergent systems.
- rDNA vectors able to direct the expression of the nucleotide sequence encoding a Cutinase gene as described above in one of the preferred hosts preferably comprise the following components:
- a secretion signal Preferred for the selected host cell
- the translated part of the gene should always end with an appropriate stop codon;
- An expression regulon (suitable for the selected host organism) situated upstream of the plus strand of the ds DNA encoding the Cutinase (component (a) ) ;
- a terminator sequence (suitable for the selected host organism) situated down stream of the plus strand of the ds DNA encoding the Cutinase (component (a) ;
- (dl) Nucleotide sequences which facilitate integration, of the ds DNA into the genome of the selected host or, (d2) an origin of replication suitable for the selected host; (el) Optionally a (auxotrophic) selection marker.
- the auxotrophic marker can consist of a coding region of the auxotrophic marker and a defective promoter; (e2) Optionally a ds DNA sequence encoding proteins involved in the maturation and/or secretion of one of the precursor forms of the Cutinase in the host selected.
- Another embodiment of this invention is the fermentative production of one of the various Cutinase variants described above.
- Such a fermentation can either be a normal batch fermentation, fed-batch fermentation or continuous fermentation.
- the selection of a process to be used depends on the host strain and the preferred down stream processing method (known per se) .
- the invention also provides a process for producing a Cutinase variant as specified herein, which comprises the steps of fermentatively cultivating an rDNA modified micro-organism containing a gene made by rDNA technique which carries at least one mutation affecting the amino acid sequence of the Cutinase thereby to confer upon the Cutinase improved activity by comparison with the corresponding parent enzyme, making a preparation of the Cutinase variant by separating the Cutinase produced by the micro-organism either from the fermentation broth, or by separating the cells of the micro-organism from the fermentation broth, disintegrating the separated cells and concentrating or part purifying the Cutinase varaint either from said broth or from said cells by physical or chemical concentration or purification methods.
- Also provided by the invention is a method for the production of a modified micro-organism capable of producing a Cutinase variant by means of rDNA techniques, characterized in that the gene coding for the Cutinase variant that is introduced into the micro-organism is fused at its 5'-end to a gene fragment encoding a (modified) pre-sequence functional as a signal- or secretion-sequence for the host organism.
- rDNA modified micro-organisms containing a Cutinase varaint gene and able to produce the Cutinase variant encoded by said gene.
- a gene (if originally present) encoding the native Cutinase is preferably removed, e.g. replaced by another structural gene.
- enzymatic detergent compositions comprising the Cutinase variants of the invention.
- Such compositions are combinations of the Cutinases variants and other ingredients which are commonly used in detergent systems, including additives for detergent compositions and fully-formulated detergent and cleaning compositions, e.g. of the kinds known per se and described for example in EP-A-258 068.
- the other components of such detergent compositions can be of any of many known kinds, for example as described in GB-A-1 372 034 (Unilever), US-A-3 950 277, US-A-4 Oil 169, EP-A-179 533 (Procter & Gamble) , EP-A-205 208 and EP-A-206 390 (Unilever) , JP-A-63-078000 (1988) , and Research Disclosure 29056 of June 1988, together with each of the several specifications mentioned therein, all of which are hereby incorporated herein by reference.
- Cutinase variant can be chosen within wide limits, for example from 10 - 20,000 LU per gram, and preferably 50 -2,000 LU per gram of the detergent composition.
- LU or lipase units are defined as they are in EP-A-258 068 (Novo Nordisk) .
- proteases such as proteases, amylases, cellulases which may also be present.
- Advantage may be gained in such detergent compositions, where protease is present together with the Cutinase variant, by selecting such protease from those having pi lower than 10.
- EP-A-271 154 (Unilever) describes a number of such proteases.
- Proteases for use together with Cutinase variants can include subtilisin of for example BPN 1 type or of many of the types of subtilisin disclosed in the literature, e.g.
- Fig. 1A Nucleotide sequence of cassette 1 of the synthetic Fusarium solani pisi cutinase gene and of the constituting oligo-nucleotides. Oligonucleotide transitions are indicated in the cassette sequence. Lower case letters refer to nucleotide positions outside the open reading frame.
- Fig. IB Nucleotide sequence of cassette 2 of the synthetic Fusarium solani pisi cutinase gene and of the constituting oligo-nucleotides. Oligonucleotide transitions are indicated in the cassette sequence.
- Fig. IC Nucleotide sequence of cassette 1 of the synthetic Fusarium solani pisi cutinase gene and of the constituting oligo-nucleotides. Oligonucleotide transitions are indicated in the cassette sequence.
- Fig. IC Nucleotide sequence of cassette 1 of the synthetic Fusarium solani pisi cutinase gene and of the constituting oli
- Fig. ID Nucleotide sequence of the synthetic cutinase gene encoding Fusarium solani pisi pre-pro-cutinase. The cutinase pre-sequence, pro-sequence and mature sequence are indicated. Also the sites used for cloning and the oligonucleotide transitions are indicated. Lower case letters refer to nucleotide positions outside the open reading frame.
- Fig. 2 Nucleotide sequence of a synthetic DNA fragment for linking the Fusarium solani pisi pro-cutinase encoding sequence to a sequence encoding a derivative of the E. coli phoA pre-sequence.
- the ribosome binding site (RBS) and the restriction enzyme sites used for cloning are indicated.
- the amino acid sequences of the encoded phoA signal sequence and part of the cutinase gene are indicated using the one-letter code.
- Fig. 3 Nucleotide sequence of cassette 8, a Sacl-Bcll fragment which encodes the fusion point of the coding sequences for the invertase pre-sequence and mature Fusarium solani pisi cutinase.
- Sall-Nrul from pUR2740 is an E. coli-S. cerevisiae shuttle vector comprising part of pBR322, an origin of replication in yeast cells derived from the 2 ⁇ m plasmid, a yeast leu2D gene and a fusion of the yeast invertase signal sequence encoding region with a plant ⁇ -galactosidase gene under the control of the yeast gal7 promoter.
- Plasmid pUR7219 is an E. coli-S.
- Plasmid pUR2740 is an E. coli-S.
- Fig. 7 Nucleotide sequence of cassettes 5, 6 and 7, comprising different types of connections of the coding sequences of the exlA pre-sequence and mature Fusarium solani pisi cutinase.
- Plasmid pUR7280 obtained by displacing the BspHI- AfIII fragment comprising the exlA open reading frame in pAW14B with a BspHI-AfIII fragment comprising the Fusarium solani pisi pre-pro- cutinase coding sequence.
- plasmid pUR7280 comprises the Fusarium solani pisi pre-pro-cutinase gene under the control of the A. niger var. awamori promoter and terminator.
- Plasmid pUR7281 obtained by introduction of both the A. nidulans amdS and A. niger var.
- Fig. 11 Partial amino acid sequences of the cutinases from Fusarium solani pisi, Colletotrichum capsici. Colletotrichum gloeosporiodes and Magnaporthe grisea, showing the location of the residues in the 3-D structure.
- Fig. 12. Compatibility of Fusarium solani pisi cutinase and Cutinase variants to a LAS-based detergent composition.
- Fig. 13 Compatibility of Fusarium solani pisi cutinase and Cutinase variants to a PAS-based detergent composition.
- Fig. 14 Compatibility of Fusarium solani pisi cutinase and Cutinase variants to a high-nonionic detergent composition.
- Fig. 15 Compatibility of Fusarium solani pisi cutinase and Cutinase variants to SDS.
- a synthetic gene encoding Fusarium solani pisi pre- pro-cutinase was constructed essentially according to the method described in EP-A-407 225 (Unilever) . Based on published nucleotide sequences of Fusarium solani pisi genes (Soliday et al. (1984) and WO-A-90/09446, Plant Genetic Systems) , a completely synthetic DNA fragment was designed which comprises a region encoding the Fusarium solani pisi pre-pro-cutinase polypeptide.
- this synthetic cutinase gene comprises several nucleotide changes through which restriction enzyme recognition sites were introduced at convenient positions within the gene without affecting the encoded amino acid sequence.
- the nucleotide sequence of the entire synthetic cutinase gene is presented in Fig. ID.
- Construction of the synthetic cutinase gene was performed by assembly of three separate cassettes starting from synthetic DNA oligonucleotides. Each synthetic DNA cassette is equipped with an EcoRI site at the start and a Hindlll site at the end. Oligonucleotides were synthesized using an Applied Biosystems 380A DNA synthesizer and purified by polyacrylamide gel electrophoresis. For the construction of each of the cassettes the procedure outlined below was followed. Equimolar amounts (50 pmol) of the oligonucleotides constituting a given cassette were mixed, phosphorylated at their 5'-end, annealed and ligated according to standard techniques.
- the resulting mixture of double stranded DNA molecules was cut with EcoRI and Hindlll, size-fractionated by agarose gel electrophoresis and recovered from the gel by electro-elution.
- the resulting synthetic DNA cassette was ligated with the 2.7 kb EcoRI-Hindlll fragment of pUC9 and transformed to Escherichia coli.
- the EcoRI-Hindlll insert of a number of clones was completely sequenced in both directions using suitable oligonucleotide primers to verify the sequence of the synthetic cassettes. Using this procedure pUR7207 (comprising cassette 1, Fig. 1A) , pUR7208 (comprising cassette 2, Fig.
- E. coli With the synthetic cutinase gene an expression vector for E. coli was constructed which is functionally similar to the one described in WO-A-90/09446 (Plant Genetic Systems) .
- a construct was designed in which the part of the synthetic gene encoding Fusarium solani pisi pro-cutinase is preceded by proper E. coli expression signals, i.e. (i) an inducible promoter, (ii) a ribosome binding site and (iii) a signal sequence which provides a translational initiation codon and provides information required for the export of the pro-cutinase across the cytoplasmic membrane.
- E. coli expression signals i.e. (i) an inducible promoter, (ii) a ribosome binding site and (iii) a signal sequence which provides a translational initiation codon and provides information required for the export of the pro-cutinase across the cytoplasmic membrane.
- a synthetic linker was designed (see Fig. 2) for fusion of a derivative of the E. coli phoA signal sequence (Michaelis et al., 1983) to the pro-sequence of the synthetic cutinase gene.
- the nucleotide sequence of this linker was such that the three C-terminal amino acid residues of the phoA signal sequence (Thr-Lys-Ala) were changed into Ala-Asn-Ala and the N-terminal amino acid residu of the cutinase pro-sequence (Leu 1, see Fig. ID) was changed into Ala.
- This construction ensures secretion of cutinase into the periplasmatic space (see WO-A-90/09446, Plant Genetic Systems) .
- the 69 bp EcoRI-Spel fragment comprising the cutinase pre-sequence and part of the pro-sequence was removed from pUR7210 and replaced with the synthetic DNA linker sequence (EcoRI-Spel fragment) providing the derivative of the E. coli phoA pre-sequence and the alterated N-terminal amino acid residu of the cutinase pro- sequence (Fig. 2) .
- the resulting plasmid was named pUR7250 and was used for the isolation of a 0.7 kb BamHI-HindlH fragment comprising a ribosome binding site and the pro- cutinase encoding region fused to the phoA signal sequence encoding region.
- This fragment was ligated with the 8.9 kb BamHI-HindlH fragment of pMMB67EH (F ⁇ rste et al., 1986) to yield pUR7220.
- the synthetic gene encoding pro-cutinase is fused to the altered version of the phoA signal sequence and placed under the control of the inducible tac-promoter.
- E. coli strain WK6 harboring pUR7220 was grown in 2 litre shakeflasks containing 0.5 litre IXTB medium (Tartof and Hobbs, 1988) consisting of: 0.017 M KH 2 P0 4 0.017 M K 2 HP0 4 12 g/1 Bacto-tryptone 24 g/1 Bacto-yeast extract 0.4 % glycerol (v/v)
- variant genes comprising alterations in the encoded amino acid sequence were constructed.
- essentially the same approach was followed as described in Example 1 for the construction of the three cassettes constituting the complete synthetic gene.
- a new version of cassette 1 was assembled using the same oligonucleotides (oligos) as described in Example 1, except for the two oligos which cover the coding triplet for the position which is to be mutated. Instead, two new oligos were used, which comprise the mutant sequence but are otherwise identical to the original oligos which they are replacing.
- Example 3A A gene coding for Fusarium solani pisi cutinase variant R17E was constructed using using a variant of cassette 1 incorporating a variant of CUTI1C IG (containing GAG instead of AGA) and a variant of CUTI1I IG (containing CTC instead of TCT) instead of CUTI1C IG and CUTI1I IG (see Fig. 1A) .
- the new cassette 1 was cloned and ⁇ equenced essentially as described in Example 1 and the about 120 bp EcoRI/Nrul DNA fragment comprising the mutation R17E was exchanged for the corresponding fragment in pUR7210, yielding pUR7240 (R17E) .
- Example 2 and the variant pro-cutinase enzyme was recovered and purified essentially as described in Example 2. Similarly Arg 17 could be replaced by Lys or by Leu.
- Example 3B A gene coding for Fusarium solani pisi cutinase variant R196E was constructed using using a variant of cassette 3 incorporating a variant of CUTI3F MH (containing GAG instead of CGG) and a variant of CUTI3M MH (containing CTC instead of CCG) instead of CUTI3F MH and CUTI3M MH (see Fig. 3A) .
- the new cassette 3 was cloned and sequenced essentially as described in Example 1 and the about 120 bp EcoRI/Nrul DNA fragment comprising the mutation R196E was exchanged for the corresponding fragment in pUR7210, yielding pUR7241 (R196E) .
- the 0.6 kB Sp_el-Hindlll fragment from this plasmids was used to replace the corresponding fragment in pUR7220, yielding the E. coli expression plasmid pUR7225 (R196E) .
- This E. coli expression plasmid was transformed to E. coli strain WK6. Transformants were grown as outlined in Example 2 and the variant pro-cutinase enzyme was recovered and purified essentially as described in Example 2.
- Arg 196 was replaced by Lys (R196K) , using a variant of CUTI3F MH (containing AAG instead of CGG) and a variant of CUTI3M MH (containing CTT instead of CCG) instead of CUTI3F MH and CUTI3M MH.
- Arg 196 was replaced by Leu (R196L) , using a variant of CUTI3F MH (containing CTT instead of CGG) and a variant of CUTI3M MH (containing AAG instead of CCG) instead of CUTI3F MH and CUTI3M MH.
- the same method was used to replace Arg 196 by Ala (R196A) .
- a gene coding for Fusarium solani pisi cutinase variant L51A was constructed using using a variant of cassette 1 incorporating a variant of CUTI1F IG (containing GCT instead of CTC) and a variant of CUTIIL IG (containing AGC instead of GAG) instead of CUTI1F IG and CUTIIL IG (see Fig. 1A) .
- the new cassette 1 was cloned and sequenced essentially as described in Example 1 and the about 120 bp EcoRI/Nrul DNA fragment comprising the mutation L51A was exchanged for the corresponding fragment in pUR7210, yielding pUR7242 (L51A) .
- Example 3E The 0.6 kB Spel- Hindlll fragment from this plasmid was used to replace the corresponding fragment in pUR7220, yielding the E. coli expression plasmid pUR7226 (R17E+R196E) .
- This E. coli expression plasmid was used to transform to E. coli strain WK6. Transformants were grown as outlined in Example 2 and the variant pro-cutinase enzyme was recovered and purified essentially as described in Example 2.
- Example 3E The 0.6 kB Spel- Hindlll fragment from this plasmid was used to replace the corresponding fragment in pUR7220, yielding the E. coli expression plasmid pUR7226 (R17E+R196E) .
- This E. coli expression plasmid was used to transform to E. coli strain WK6. Transformants were grown as outlined in Example 2 and the variant pro-cutinase enzyme was recovered and purified essentially as described in Example 2.
- a Cutinase variant with two modifications can be constructed.
- the construction of pUR7240 R17E
- example 3C the construction of the DNA fragment comprising the mutation L51A has been described.
- the Bcll/Apal fragment of pUR7242 was exchanged for the corresponding fragment in pUR7240, yielding pUR7244 (R17E+L51A) .
- the 0.6 kB Spel-Hindlll fragment from this plasmids was used to replace the corresponding fragment in pUR7220, yielding the E. coli expression plasmid pUR7246 (R17E+L51A) .
- This E. coli expression plasmid was used to transform E. coli strain WK6. Transformants were grown as outlined in Example 2 and the variant pro-cutinase enzyme was recovered and purified essentially as described in Example 2.
- an expression vector was constructed in which a synthetic gene encoding the mature cutinase is preceded by the pre-sequence of S ⁇ . cerevisiae invertase (Taussig and Carlsson, 1983) and the strong, inducible gal7 promoter (Nogi and Fukasawa, 1983) .
- an adaptor fragment was synthetized in which the coding sequence for the invertase pre-sequence is fused to the sequence encoding the N-terminus of mature cutinase.
- This fragment was assembled as an EcoRI-Hindlll cassette in pUC9 essentially as described in Example 1 (cassette 8, see Fig. 3), yielding pUR7217.
- Plasmids pUR7210 and pUR7217 were transformed to E. coli JM110 (a strain lacking the dam methylase activity) and the 2.8 kb Bcll-Hindlll fragment of pUR7217 was ligated with the 0.6 kb Bell-Hindlll fragment of pUR7210, yielding pUR7218 in which the nucleotide sequence coding for the mature cutinase polypeptide is fused with part of the S. cerevisiae invertase pre-sequence coding region.
- the expression vector pUR2741 (see Fig. 4) was derived from pUR2740 (Verbakel, 1991, see Fig. 6) by isolation of the 8.9 kb Nrul-Sall fragment of pUR2740, filling in the Sail protruding end with Klenow polymerase, and recircularization of the fragment.
- the 7.3 kb Sacl- Hindlll fragment of pUR2741 was ligated with the 0.7 kb Sacl- HindHI fragment of pUR7218, yielding pUR7219 (see Fig. 5).
- the E. coli-S. cerevisiae shuttle plasmid pUR7219 contains a origin for replication in S. cerevisiae strains harboring the 2 ⁇ plasmid (cir + strains) , a promoter- deficient version of the S. cerevisiae Leu2 gene permitting selection of high copy number transformants in S. cerevisiae leu2 ⁇ strains, and the synthetic gene encoding the mature part of Fusarium solani pisi cutinase operably linked to the S. cerevisiae invertase pre-sequence under the regulation of the strong, inducible S. cerevisiae gal7 promoter.
- S. cerevisiae strain SU50 (a, cir°, leu2, his4, canl) , which is identical to strain YT6-2-1L (Erhart and Hollenberg, 1981) , was co-transformed with an equimolar mixture of the 2 ⁇ S. cerevisiae plasmid and pUR7219 using a standard protocol for electroporation of yeast cells.
- S. cerevisiae strain SU51 harboring pUR7219 was grown in 1 litre shakefla ⁇ ks containing 0.2 litre MM medium consisting of:
- Example 4 and the variant enzyme produced was recovered from the culture broth as described in Examples 4 and 1.
- a BspHI site (5'-TCATGA-3') comprising the first codon (ATG) of the exlA gene and an Aflll site (5'-CTTAAG- 3 ' ) , comprising the stopcodon (TAA) of the exlA gene facilitated the construction of pUR7280.
- the construction was carried out as follows: pAW14B (7.9 kb) was cut partially with BspHI and the linearized plasmid (7.9 kb) was isolated from an agarose gel. Subsequently the isolated 7.9 kb fragment was cut with BsmI, which cuts a few nucleotides downstream of the BspHI site of interest, to remove plasmids linearized at other BspHI sites. The fragments were separated on an agarose gel and the 7.9 kb BspHI-BsmI fragment was isolated. This was partially cut with AfIII and the resulting 7.2 kb BspHI-AflH fragment was isolated.
- the 0.7 kb BspHI-AfIII fragment of pUR7210 comprising the entire open reading frame coding for Fusarium solani pisi pre-pro-cutinase was ligated with the 7.2 kb BspHI-AflH fragment of pAW14B, yielding pUR7280.
- the constructed vector (pUR7280) can subsequently transferred to moulds (for example Aspergillus niger. Aspergillus niger var. awamori, etc) by means of conventional co-transformation techniques and the pre-pro-cutinase gene can then be expressed via induction of the endoxylanasell promoter.
- the constructed rDNA vector can also be provided with conventional selection markers (e.g.
- amdS or pyrG, hygromycin etc. can be transformed with the resulting rDNA vector to produce the desired protein.
- the amdS and pyrG selection markers were introduced in the expression vector, yielding pUR7281 (Fig. 10) .
- a NotI site was created by converting the EcoRI site (present 1.2 kb upstream of the ATG codon of the pre-pro- cutinase gene) into a NotI site using a synthetic oligonucleotide (5'-AATTGCGGCCGC-3•) , yielding pUR7282.
- Suitable DNA fragment comprising the entire A. nidulans a dS gene and the A. niger var. awamori pyrG gene together with their own promoters and terminators were equiped with flanking NotI sites and introduced in the NotI site of PUR7282, yielding pUR7281 (Fig. 10).
- Cassette 7 is identical with cassette 6, but here the N-terminal residue of the encoded mature cutinase polypeptide has been changed from the original Glycine into a Serine residue in order to better fit the requirements for cleavage of the signal peptide.
- Cassettes 5, 6 and 7 were assembled from synthetic oligonucleotides essentially as described in Example 1 (see Fig. 7). Cassette 5 was used to displace the 0.1 kb EcoRI- Spel fragment of pUR7210, yielding pUR7287.
- Cassettes 6 and 7 were used to displace the 0.1 kb EcoRI-BclI fragment of pUR7210, yielding pUR7288 and pUR7289, respectively.
- Aspergillus strains transformed with either of the expression vectors pUR7280, pUR7281, pUR7290, pUR7291, pUR7292 (containing the Fusarium solani pisi mature cutinase encoding region with or without the corresponding pro- sequence and either the cutinase signal sequence or the exlA signal sequence under the control of A. niger var. awamori exlA promoter and terminator) were grown under the following conditions: multiple 1 litre shake flasks with 400 ml synthetic media (pH 6.5) were inoculated with spores (final concentration: 10E6/ml) .
- the medium had the following composition (AW Medium) : sucrose 10 g/1
- RNA preparations were isolated using the guanidinium thiocyanate method and purified by cesium chloride density gradient centrifugation, essentially as described by Sambrook et al. (1989). PolyA(+) mRNA fractions were isolated using a polyATtract mRNA isolation kit (Promga) .
- the polyA(+) mRNA fractions were used in a Northern hybridization analysis using a cDNA fragment from the Fusarium solani pisi cutinase gene as a probe according to standard techniques, to verify the expression of cutinase-related genes.
- Preparations of mRNA comprising material capable of hybridizing with the probe were used for the synthesis of cDNA using a ZAP cDNA synthesis kit (Stratagene, La Jolla) according to the instructions of the supplier, yielding cDNA fragments with an Xhol cohesive end flanking the poly-A region and an EcoRI adaptor at the other end.
- the obtained cDNA fragments were used for the construction of expression libraries by directional cloning in the sense orientation in lambda ZAPII vectors (Stratagene, La Jolla) , allowing expression of ⁇ -galactosidase fusion proteins (Huse et al.,1988) . These libraries were screened using antiserum raised against Fusarium solani pisi cutinase. Alternatively, the synthesized cDNA fractions were subjected to PCR-screening using cutinase specific primers (see table 2) . These primers were derived from comparison of the amino acid sequence of several fungal Cutinase genes (Ettinger et al., 1987).
- the PCR screening techique using Cutinase specific primers was also applied directly to genomic DNA of some fungal strains, using genomic DNA of Fusarium solani pisi as a positive control.
- genomic DNA genomic DNA of Fusarium solani pisi as a positive control.
- the PCR fragment was purified by gel electroforesis and isolated from the gel.
- Genomic DNA was digested with various restriction enzymes and analyzed by Southern hybridization using either the analogous cDNA insert (expression library approach) or the PCR fragment (PCR screening approach) or the Fusarium solani pisi cutinase gene (other strains) as a probe, and a physical map of the cutinase genes was constructed.
- genomic DNA was size-fractionated by gel electroforesis and fragments of the appropriate size were isolated from the gel and subcloned in pUC19.
- genomic libraries were screened with the corresponding cDNA insert (expression library approach) or the PCR fragment (PCR screening approach) , yielding clones comprising the genomic copy of the cutinase genes. These genes were sequenced in both directions. Introns were identified by sequencing the corresponding cDNA or by comparison with other Cutinase sequences (Ettinger et al., 1987) . The N-terminal end of the mature cutinase polypeptide was also deduced from such a comparison.
- R17E, R196E and R17E+R196E to various anionic surfactants.
- SDS Sodium Dodecyl Sulphate
- Test cloths made of woven polyester/cotton were soiled with pure olive oil. Each tests cloth was then incubated in 30 ml wash liquor in a 100 ml polystyrene bottle. The bottles were agitated in a Miele TMT washing machine filled with water and using a normal 40°C main wash programme. The wash liquor consisted of 2 grams per litre (at 27°FH) of washing powders A and B of Example 9.
- Cutinase varaiant R17E relative to wild-type Fusarium solani pisi cutinase under various wash conditions is evident. For comparison, the same experiments were also carried out with Lipolase (TM) . Under all conditions, the Cutinase variant R17E was superior.
- TM Lipolase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94902775A EP0802981A1 (en) | 1992-12-23 | 1993-12-09 | Modified cutinases, dna, vector and host |
AU57000/94A AU5700094A (en) | 1992-12-23 | 1993-12-09 | Modified cutinases, dna, vector and host |
SK802-95A SK80295A3 (en) | 1992-12-23 | 1993-12-09 | Modified cutinases, method of its production, dna, vector and host |
BR9307722-0A BR9307722A (en) | 1992-12-23 | 1993-12-09 | Cutinase variant of an original cutinase, process to produce a cutinase variant, rdna modified microorganism, polynucleotide, recombinant DNA vector, and enzymatic detergent composition |
PL93309403A PL309403A1 (en) | 1992-12-23 | 1993-12-09 | Modified cutinases, dna, vector and host |
JP6514771A JPH08504589A (en) | 1992-12-23 | 1993-12-09 | Modified cutinase, DNA, vector and host |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92204079.5 | 1992-12-23 | ||
EP92204079 | 1992-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994014964A1 true WO1994014964A1 (en) | 1994-07-07 |
Family
ID=8211173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1993/003551 WO1994014964A1 (en) | 1992-12-23 | 1993-12-09 | Modified cutinases, dna, vector and host |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0802981A1 (en) |
JP (1) | JPH08504589A (en) |
CN (1) | CN1090329A (en) |
AU (1) | AU5700094A (en) |
BR (1) | BR9307722A (en) |
CA (1) | CA2151038A1 (en) |
CZ (1) | CZ163995A3 (en) |
HU (1) | HUT71315A (en) |
PL (1) | PL309403A1 (en) |
SK (1) | SK80295A3 (en) |
WO (1) | WO1994014964A1 (en) |
ZA (1) | ZA939416B (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995022615A1 (en) * | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1996000292A1 (en) * | 1994-06-23 | 1996-01-04 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996018729A1 (en) * | 1994-12-13 | 1996-06-20 | Genencor International, Inc. | Fusarium isolate and lipases, cutinases and enzyme compositions derived therefrom |
WO1997007202A1 (en) * | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
WO1997041212A1 (en) * | 1996-04-25 | 1997-11-06 | Novo Nordisk A/S | Alkaline lipolytic enzyme |
WO1997043376A1 (en) * | 1996-05-15 | 1997-11-20 | The Procter & Gamble Company | Detergent compositions comprising lipolytic enzymes |
WO1998006810A1 (en) * | 1996-08-16 | 1998-02-19 | The Procter & Gamble Company | Detergent compositions comprising antibody controlled lipolytic activity |
US5892013A (en) * | 1990-09-13 | 1999-04-06 | Novo Nordisk A/S | Lipase variants |
WO2000034450A1 (en) * | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
US6495357B1 (en) | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
US6537790B1 (en) | 1999-06-04 | 2003-03-25 | Sumitomo Chemical Company, Limited | Esterase genes and uses of the same |
US6815190B1 (en) * | 1998-04-12 | 2004-11-09 | Novozymes A/S | Cutinase variants |
US6960459B2 (en) | 2000-06-02 | 2005-11-01 | Novozymes A/S | Cutinase variants |
WO2008110513A1 (en) | 2007-03-09 | 2008-09-18 | Novozymes A/S | Thermostable asparaginases |
US7951267B2 (en) | 2001-05-21 | 2011-05-31 | Kim Borch | Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer |
WO2011078949A1 (en) | 2009-12-21 | 2011-06-30 | Danisco Us Inc. | Surfactants that improve the cleaning of lipid-based stains treated with lipases |
WO2012001145A1 (en) | 2010-07-01 | 2012-01-05 | Novozymes A/S | Bleaching of pulp |
EP2495316A2 (en) | 2006-06-21 | 2012-09-05 | Novozymes North America, Inc. | Desizing and scouring process of starch |
WO2012149192A1 (en) | 2011-04-28 | 2012-11-01 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2013016115A1 (en) | 2011-07-22 | 2013-01-31 | Novozymes North America, Inc. | Processes for pretreating cellulosic material and improving hydrolysis thereof |
WO2013036898A2 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Improving properties of paper materials |
WO2014012506A1 (en) | 2012-07-18 | 2014-01-23 | Novozymes A/S | Method of treating polyester textile |
EP2740840A1 (en) | 2012-12-07 | 2014-06-11 | Novozymes A/S | Improving drainage of paper pulp |
US9115346B2 (en) | 2002-01-16 | 2015-08-25 | Novozymes A/S | Lipolytic enzymes |
WO2016007309A1 (en) | 2014-07-07 | 2016-01-14 | Novozymes A/S | Use of prehydrolysate liquor in engineered wood |
EP3097229B1 (en) | 2014-01-26 | 2018-12-05 | Novozymes A/S | A method to produce an antimicrobial polyester textile using cutinase |
WO2019145020A1 (en) * | 2018-01-23 | 2019-08-01 | Calik Denim Tekstil San. Ve Tic. A.S. | Processes and installations for dyeing synthetic fibers and dyed fibers and fabrics containing said dyed fibers |
WO2021018751A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Enzymatic treatment of paper pulp |
WO2021239950A1 (en) | 2020-05-29 | 2021-12-02 | Novozymes A/S | Method for controlling slime in a pulp or paper making process |
WO2022263553A1 (en) | 2021-06-16 | 2022-12-22 | Novozymes A/S | Method for controlling slime in a pulp or paper making process |
WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
WO2025071996A1 (en) | 2023-09-28 | 2025-04-03 | Danisco Us Inc. | Variant cutinase enzymes with improved solubility and uses thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651334B (en) * | 2013-11-20 | 2019-07-09 | 丰益(上海)生物技术研发中心有限公司 | The mould lipase Variant of branch spore that anionic surfactant tolerance improves |
CN109153964B (en) | 2016-03-01 | 2023-06-13 | 芬德集团公司 | Filamentous fungal biomats, methods of production and use thereof |
CN119014534A (en) | 2017-08-30 | 2024-11-26 | 芬德集团公司 | Edible composition with filamentous fungi and bioreactor system for cultivation thereof |
EP3930468B1 (en) | 2019-02-27 | 2024-07-10 | The Fynder Group, Inc. | Food materials comprising filamentous fungal particles |
CN114901902B (en) | 2019-06-18 | 2024-06-21 | 芬德集团公司 | Fungal fabric materials and leather analogs |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988009367A1 (en) * | 1987-05-29 | 1988-12-01 | Genencor, Inc. | Cutinase cleaning composition |
EP0375102A2 (en) * | 1988-12-19 | 1990-06-27 | The Clorox Company | Enzymatic peracid bleaching system with modified enzyme |
WO1990009446A1 (en) * | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
WO1992005249A1 (en) * | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
WO1994003578A1 (en) * | 1992-07-31 | 1994-02-17 | Unilever N.V. | Enzymatic detergent compositions |
-
1993
- 1993-12-09 CA CA002151038A patent/CA2151038A1/en not_active Abandoned
- 1993-12-09 EP EP94902775A patent/EP0802981A1/en not_active Withdrawn
- 1993-12-09 HU HU9501874A patent/HUT71315A/en unknown
- 1993-12-09 SK SK802-95A patent/SK80295A3/en unknown
- 1993-12-09 WO PCT/EP1993/003551 patent/WO1994014964A1/en not_active Application Discontinuation
- 1993-12-09 CZ CZ951639A patent/CZ163995A3/en unknown
- 1993-12-09 AU AU57000/94A patent/AU5700094A/en not_active Abandoned
- 1993-12-09 JP JP6514771A patent/JPH08504589A/en active Pending
- 1993-12-09 PL PL93309403A patent/PL309403A1/en unknown
- 1993-12-09 BR BR9307722-0A patent/BR9307722A/en not_active Application Discontinuation
- 1993-12-15 ZA ZA939416A patent/ZA939416B/en unknown
- 1993-12-23 CN CN93121760A patent/CN1090329A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988009367A1 (en) * | 1987-05-29 | 1988-12-01 | Genencor, Inc. | Cutinase cleaning composition |
EP0375102A2 (en) * | 1988-12-19 | 1990-06-27 | The Clorox Company | Enzymatic peracid bleaching system with modified enzyme |
WO1990009446A1 (en) * | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
WO1992005249A1 (en) * | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
WO1994003578A1 (en) * | 1992-07-31 | 1994-02-17 | Unilever N.V. | Enzymatic detergent compositions |
Non-Patent Citations (4)
Title |
---|
ETTINGER ET AL.: "Structure of cutinase gene, cDNA, and the derived amino acid sequence from phytopathogenic fungi", BIOCHEMISTRY, vol. 26, no. 24, 1 December 1987 (1987-12-01), pages 7883 - 7892, XP001317731 * |
MARTINEZ ET AL.: "Fusarium solani cutinase is a lipolytic enzyme with a catalytic serine accessible to solvent", NATURE, vol. 356, no. 6370, 16 April 1992 (1992-04-16), pages 615 - 618, XP000565689, DOI: doi:10.1038/356615a0 * |
SOLIDAY ET AL.: "Cloning and structure determination of cDNA for cutinase, an enzyme involved in fungal penetration of plants", PROC. NATL ACAD. SCI. USA, vol. 81, no. 13, July 1984 (1984-07-01), pages 3939 - 3943, XP001317730 * |
SWEIGARD ET AL.: "Cloning and analysis of CUT1, a cutinase gene from Magnaporthe grisea", MOL. GEN. GENET., vol. 232, no. 2, March 1992 (1992-03-01), pages 174 - 182, XP002091582 * |
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5892013A (en) * | 1990-09-13 | 1999-04-06 | Novo Nordisk A/S | Lipase variants |
US5976855A (en) * | 1994-02-22 | 1999-11-02 | Novo Nordisk A/S | Method of preparing a variant of a lipolytic enzyme |
WO1995022615A1 (en) * | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
CN1077598C (en) * | 1994-02-22 | 2002-01-09 | 诺沃奇梅兹有限公司 | A method of preparing a variant of a lipolytic enzyme |
WO1996000292A1 (en) * | 1994-06-23 | 1996-01-04 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996018729A1 (en) * | 1994-12-13 | 1996-06-20 | Genencor International, Inc. | Fusarium isolate and lipases, cutinases and enzyme compositions derived therefrom |
US5990069A (en) * | 1994-12-13 | 1999-11-23 | Genencor International, Inc. | Fusarium isolate and lipases, cutinases and enzyme compositions derived therefrom |
US7157262B2 (en) | 1995-07-14 | 2007-01-02 | Novozymes A/S | Lipolytic enzymes |
US6495357B1 (en) | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
WO1997007202A1 (en) * | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
WO1997041212A1 (en) * | 1996-04-25 | 1997-11-06 | Novo Nordisk A/S | Alkaline lipolytic enzyme |
US6350604B1 (en) | 1996-04-25 | 2002-02-26 | Novozymes A/S | Alkaline lipolytic enzyme |
WO1997043376A1 (en) * | 1996-05-15 | 1997-11-20 | The Procter & Gamble Company | Detergent compositions comprising lipolytic enzymes |
WO1998006810A1 (en) * | 1996-08-16 | 1998-02-19 | The Procter & Gamble Company | Detergent compositions comprising antibody controlled lipolytic activity |
WO1998007817A1 (en) * | 1996-08-16 | 1998-02-26 | The Procter & Gamble Company | Detergent compositions comprising antibody controlled lipolytic activity |
US6815190B1 (en) * | 1998-04-12 | 2004-11-09 | Novozymes A/S | Cutinase variants |
WO2000034450A1 (en) * | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
KR100748061B1 (en) * | 1998-12-04 | 2007-08-09 | 노보자임스 에이/에스 | Cutinase variant |
US6537790B1 (en) | 1999-06-04 | 2003-03-25 | Sumitomo Chemical Company, Limited | Esterase genes and uses of the same |
US6812008B2 (en) | 1999-06-04 | 2004-11-02 | Sumitomo Chemical Company, Limited | Esterase genes and uses of the same |
US6828129B2 (en) | 1999-06-04 | 2004-12-07 | Sumitomo Chemical Company Limited | Esterase genes and uses of the same |
US6960459B2 (en) | 2000-06-02 | 2005-11-01 | Novozymes A/S | Cutinase variants |
US7951267B2 (en) | 2001-05-21 | 2011-05-31 | Kim Borch | Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer |
US9115346B2 (en) | 2002-01-16 | 2015-08-25 | Novozymes A/S | Lipolytic enzymes |
EP2495316A2 (en) | 2006-06-21 | 2012-09-05 | Novozymes North America, Inc. | Desizing and scouring process of starch |
WO2008110513A1 (en) | 2007-03-09 | 2008-09-18 | Novozymes A/S | Thermostable asparaginases |
EP2851424A1 (en) | 2007-03-09 | 2015-03-25 | Novozymes A/S | Thermostable asparaginases |
WO2011078949A1 (en) | 2009-12-21 | 2011-06-30 | Danisco Us Inc. | Surfactants that improve the cleaning of lipid-based stains treated with lipases |
EP3470504A1 (en) | 2009-12-21 | 2019-04-17 | Danisco US Inc. | Surfactants that improve the cleaning of lipid-based stains treated with lipases |
WO2012001145A1 (en) | 2010-07-01 | 2012-01-05 | Novozymes A/S | Bleaching of pulp |
WO2012149192A1 (en) | 2011-04-28 | 2012-11-01 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2013016115A1 (en) | 2011-07-22 | 2013-01-31 | Novozymes North America, Inc. | Processes for pretreating cellulosic material and improving hydrolysis thereof |
WO2013036898A2 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Improving properties of paper materials |
WO2014012506A1 (en) | 2012-07-18 | 2014-01-23 | Novozymes A/S | Method of treating polyester textile |
EP2740840A1 (en) | 2012-12-07 | 2014-06-11 | Novozymes A/S | Improving drainage of paper pulp |
WO2014086976A1 (en) | 2012-12-07 | 2014-06-12 | Novozymes A/S | Improving drainage of paper pulp |
EP3097229B1 (en) | 2014-01-26 | 2018-12-05 | Novozymes A/S | A method to produce an antimicrobial polyester textile using cutinase |
WO2016007309A1 (en) | 2014-07-07 | 2016-01-14 | Novozymes A/S | Use of prehydrolysate liquor in engineered wood |
WO2019145020A1 (en) * | 2018-01-23 | 2019-08-01 | Calik Denim Tekstil San. Ve Tic. A.S. | Processes and installations for dyeing synthetic fibers and dyed fibers and fabrics containing said dyed fibers |
CN111801461A (en) * | 2018-01-23 | 2020-10-20 | 卡特科丹宁纺织品贸易有限公司 | Method and device for dyeing synthetic fibres, dyed fibres and fabrics containing same |
CN111801461B (en) * | 2018-01-23 | 2023-09-15 | 卡特科丹宁纺织品贸易有限公司 | Method and device for dyeing synthetic fibers, dyed fibers and fabrics containing the same |
WO2021018751A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Enzymatic treatment of paper pulp |
WO2021239950A1 (en) | 2020-05-29 | 2021-12-02 | Novozymes A/S | Method for controlling slime in a pulp or paper making process |
WO2022263553A1 (en) | 2021-06-16 | 2022-12-22 | Novozymes A/S | Method for controlling slime in a pulp or paper making process |
WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
WO2025071996A1 (en) | 2023-09-28 | 2025-04-03 | Danisco Us Inc. | Variant cutinase enzymes with improved solubility and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
HU9501874D0 (en) | 1995-08-28 |
HUT71315A (en) | 1995-11-28 |
JPH08504589A (en) | 1996-05-21 |
AU5700094A (en) | 1994-07-19 |
PL309403A1 (en) | 1995-10-02 |
CA2151038A1 (en) | 1994-07-07 |
EP0802981A1 (en) | 1997-10-29 |
CZ163995A3 (en) | 1995-11-15 |
BR9307722A (en) | 1999-08-31 |
SK80295A3 (en) | 1995-10-11 |
CN1090329A (en) | 1994-08-03 |
ZA939416B (en) | 1995-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0802981A1 (en) | Modified cutinases, dna, vector and host | |
AU4700793A (en) | Enzymatic detergent compositions | |
WO1996000292A1 (en) | Modified pseudomonas lipases and their use | |
WO1995035381A1 (en) | Modified pseudomonas lipases and their use | |
WO1994014963A1 (en) | Modified cutinases, dna, vector and host | |
JP4287149B2 (en) | Lipase mutant | |
EP0548228B1 (en) | Lipase variants | |
EP0407225A1 (en) | Enzymes and enzymatic detergent compositions | |
EP0673427B1 (en) | Enzymatic process using enzymes immobilized on the cell wall of a eukaryotic microbial cell by producing a fusion protein | |
KR101739770B1 (en) | Novel fungal protease and use thereof | |
WO1996013580A1 (en) | An enzyme with lipolytic activity | |
US5658871A (en) | Microbial lipase muteins and detergent compositions comprising same | |
CN102712878A (en) | Detergent compositions containing bacillus subtilis lipase and methods of use thereof | |
JPH11510699A (en) | New lipolytic enzyme | |
WO1997004079A1 (en) | A modified enzyme with lipolytic activity | |
EP0746618A1 (en) | A method of preparing a variant of a lipolytic enzyme | |
JP2003526319A (en) | Lipase mutant | |
US20080020118A1 (en) | Polypeptides Having Lipase Activity and Polynucleotides Encoding Same | |
EP2408805A2 (en) | Fungal cutinase from magnaporthe grisea | |
WO1993000426A1 (en) | Mammalian pancreatic lipase and variant thereof | |
EP1293571A2 (en) | Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein | |
WO1993011254A1 (en) | Protease-stable proteins | |
WO2000005349A1 (en) | Phenol oxidizing enzymes | |
MXPA97003062A (en) | An enzyme with activity lipolit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2151038 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994902775 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 80295 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1995-1639 Country of ref document: CZ |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV1995-1639 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1995-1639 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1994902775 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994902775 Country of ref document: EP |